CRISPR Therapeutics
CRSP
#3181
Rank
A$6.83 B
Marketcap
A$70.93
Share price
4.52%
Change (1 day)
20.37%
Change (1 year)

Financial Statements

Thumbnail CRISPR Therapeutics Financial Statement 2025

Financial Statement 2025

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2024

Financial Statement 2024

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2023

Financial Statement 2023

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2022

Financial Statement 2022

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2021

Financial Statement 2021

Language: English

View Financial Statement